When comparing the T-cell activation in small vs. large tumors, we observed a similar outcome; PD-L1 blockade induced robust tumor-specific T-cell increase in small tumors, while the same treatment had limited effects on those in advanced tumors (Fig. 1c). The gene discussed is CD274; the disease is neoplasm.